Literature DB >> 26116800

The Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH.

Rohit Loomba1, Naga Chalasani2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26116800     DOI： 10.1053/j.gastro.2015.06.016

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  23 in total

1.  Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.

Authors:  Rohit Loomba; Nicholas Schork; Chi-Hua Chen; Ricki Bettencourt; Ana Bhatt; Brandon Ang; Phirum Nguyen; Carolyn Hernandez; Lisa Richards; Joanie Salotti; Steven Lin; Ekihiro Seki; Karen E Nelson; Claude B Sirlin; David Brenner
Journal:  Gastroenterology       Date:  2015-08-20       Impact factor: 22.682

2.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors:  Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

3.  Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis.

Authors:  Cyrielle Caussy; Meera Soni; Jeffrey Cui; Ricki Bettencourt; Nicholas Schork; Chi-Hua Chen; Mahdi Al Ikhwan; Shirin Bassirian; Sandra Cepin; Monica P Gonzalez; Michel Mendler; Yuko Kono; Irine Vodkin; Kristin Mekeel; Jeffrey Haldorson; Alan Hemming; Barbara Andrews; Joanie Salotti; Lisa Richards; David A Brenner; Claude B Sirlin; Rohit Loomba
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

4.  DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis.

Authors:  Rohit Loomba; Yevgeniy Gindin; Zhaoshi Jiang; Eric Lawitz; Stephen Caldwell; C Stephen Djedjos; Ren Xu; Chuhan Chung; Robert P Myers; G Mani Subramanian; Zachary Goodman; Michael Charlton; Nezam H Afdhal; Anna Mae Diehl
Journal:  JCI Insight       Date:  2018-01-25

5.  Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.

Authors:  Saumya Jayakumar; Stephen A Harrison; Rohit Loomba
Journal:  Curr Hepatol Rep       Date:  2016-04-21

6.  Nonalcoholic Steatohepatitis and Endpoints in Clinical Trials.

Authors:  William N Hannah; Dawn M Torres; Stephen A Harrison
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-12

Review 7.  Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease?

Authors:  David H Ipsen; Jens Lykkesfeldt; Pernille Tveden-Nyborg
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

8.  Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.

Authors:  Jeffrey Cui; Elhamy Heba; Carolyn Hernandez; William Haufe; Jonathan Hooker; Michael P Andre; Mark A Valasek; Hamed Aryafar; Claude B Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2015-12-18       Impact factor: 17.425

9.  Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study.

Authors:  Jeffrey Cui; Chi-Hua Chen; Min-Tzu Lo; Nicholas Schork; Ricki Bettencourt; Monica P Gonzalez; Archana Bhatt; Jonathan Hooker; Katherine Shaffer; Karen E Nelson; Michelle T Long; David A Brenner; Claude B Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2016-07-25       Impact factor: 17.425

10.  Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease.

Authors:  Miriam B Vos; Lara Dimick-Santos; Ruby Mehta; Stephanie O Omokaro; Johannes Taminiau; Elmer Schabel; David E Kleiner; Peter Szitanyi; Piotr Socha; Jeffrey B Schwimmer; Stephanie Noviello; Debra G Silberg; Richard Torstenson; Veronica Miller; Joel E Lavine
Journal:  Gastroenterology       Date:  2019-09-12       Impact factor: 22.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.